Feasibility of a new electronic patient-reported outcome (ePRO) system for an advanced therapy clinical trial in immune-mediated inflammatory disease (PROmics): protocol for a qualitative feasibility study

INTRODUCTION: The use of electronic patient-reported outcome (ePRO) systems to capture PRO data in clinical trials is increasing; however, their feasibility, acceptability and utility in clinical trials of advanced therapy medicinal products (ATMPs) are not yet well understood. This protocol describ...

Descripción completa

Detalles Bibliográficos
Autores principales: Hughes, Sarah E, McMullan, Christel, Rowe, Anna, Retzer, Ameeta, Malpass, Rebecca, Bathurst, Camilla, Davies, Elin Haf, Frost, Chris, McNamara, Gary, Harding, Rosie, Price, Gary, Wilson, Roger, Walker, Anita, Newsome, Philip N, Calvert, Melanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Immunology (Including Allergy)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9453996/
https://www.ncbi.nlm.nih.gov/pubmed/36691123
http://dx.doi.org/10.1136/bmjopen-2022-063199

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9453996/
https://www.ncbi.nlm.nih.gov/pubmed/36691123
http://dx.doi.org/10.1136/bmjopen-2022-063199

Ejemplares similares